PubMed COVID-19 Clinical Care

CONCLUSIONS: Isavuconazole plasma levels can be negatively affected by patients' risk factors, supportive renal replacement and ECMO therapy. Future prospective studies analysing the relevance of isavuconazole drug levels in ICU patient outcome are

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].

CONCLUSION: It is concluded that the TR-Ag are configured as a cost-effective alternative for the SUS in the detection of the new Coronavirus. The strategy becomes economically favorable for the expansion of testing, combating the COVID-19 pandemic

The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) represented the first fully in-person conference since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic began. CROI continues as the premier conference

[This corrects the article DOI: 10.1016/j.heliyon.2023.e17577.].

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].

[This corrects the article DOI: 10.1016/j.heliyon.2023.e15032.].